BRIDGET MORRIS: Open Payments
NPI 1952959140 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 18 payments from 11 companies in 2025. Trend: 2023 $207 · 2024 $197 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $89 |
| Madrigal Pharmaceuticals | 2 | $69 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Celltrion USA Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: REZDIFFRA, ENTYVIO, TERLIVAZ, XIFAXAN, VELSIPITY, The Cologuard Plus Collection Kit, EOHILIA, IQIRVO.
Industry payments across MD — which companies pay providers there.
